drugset / Trial / NCT04406259

Atrioventricular Block and Cluster Headache (SEVA)

NCT04406259

Phase 4 Active not recruiting 60 enrolled Centre Hospitalier Universitaire de Nice
NaSingle-groupOpen-labelOther

Summary

Verapamil is a calcium channel blocker widely used to treat cardiovascular diseases however it is also the first line treatment in the prevention of cluster headaches. In France, its prescription in that indication is based on compliance with the Temporary Recommendation for Use (RTU) that insists on the possible the cardiac side effects that can occur as the doses required for cluster headache are significantly higher than the doses used in cardiology.

Timeline

Start
2020-11-02
Primary completion
2025-09-05
Completion
2027-09-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Verapamil Other / unclassified